Siemens Healthineers Starts Carve-Out of Diagnostics Business as Olyrian Diagnostics
Siemens Healthineers has begun carving out its in vitro diagnostics unit, which will operate as Olyrian Diagnostics and become a standalone company by mid-2028.
Latest Articles
Editor's Top Picks
FDA Clears Rapid Blood Test to Distinguish Bacterial From Viral Infections
The Beckman Coulter assay delivers results in as little as 15 minutes on existing immunoassay analyzers, potentially helping clinicians make faster treatment decisions.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
Nova Biomedical Corrects Glucose Meters Over Risk of Misassigned Patient Results
Screen retention errors can misassign patient glucose results in electronic records, leading to one reported injury and a planned software update.
Equipment & Supply Spotlight
DNA/RNA Extraction Kit Designed to Simplify Molecular Testing Receives CE-IVD Mark
The kit allows laboratories to extract DNA and RNA from a range of clinical specimens using a single method.
News, Know-How & Standards
Disease Detection & Understanding
Prenatal STI Screening Twice During Pregnancy Cuts Preterm Birth Risk by 23%
A clinical trial found that twice-per-pregnancy STI screening reduced preterm birth risk by 23% versus standard care.
